Literature DB >> 7145036

Further evidence for a relationship between changes in GABA concentration in rat brain and enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shock.

A R Green, K Sant, J M Bowdler, P J Cowen.   

Abstract

Administration of bicuculline (3.5 mg/kg i.p.) or pentylenetetrazol (30 mg/kg i.p.) 3 min before each of a series of 5 electroconvulsive shocks (ECS), given over 10 days (1, 3, 5, 8 and 10), prevented the enhanced behavioural responses to the dopamine agonist apomorphine and the 5-hydroxytryptamine agonist quipazine 24 hr after the last application of ECS. Pretreatment with these antagonists of gamma-aminobutyric acid (GABA) also abolished the rise in the concentration of GABA in the corpus striatum, normally seen after repeated ECS. Taken with data showing that the change in GABA concentration occurred at times when enhanced monoamine-mediated behavioural responses were seen, these results suggest that the enhanced behavioural responses following repeated ECS might be associated with changes in GABA function. Daily injection for 8 days with pentylenetetrazol (30 mg/kg) resulted in enhanced apomorphine-mediated behaviour. However, there was no change in the concentration of striatal GABA at this time.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7145036     DOI: 10.1016/0028-3908(82)90110-1

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  8 in total

1.  Anxiety in major depression and cerebrospinal fluid free gamma-aminobutyric acid.

Authors:  J John Mann; Maria A Oquendo; Kalycia Trishana Watson; Maura Boldrini; Kevin M Malone; Steven P Ellis; Gregory Sullivan; Thomas B Cooper; Shan Xie; Dianne Currier
Journal:  Depress Anxiety       Date:  2014-05-27       Impact factor: 6.505

2.  Some anticonvulsant drugs alter monoamine-mediated behaviour in mice in ways similar to electroconvulsive shock; implications for antidepressant therapy.

Authors:  A R Green; P Johnson; J A Mountford; V L Nimgaonkar
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

3.  Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine- and dopamine-mediated behaviours and 5-HT2 receptor number in frontal cortex.

Authors:  A R Green; D J Heal; P Johnson; B E Laurence; V L Nimgaonkar
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

4.  Increased 5-HT2 receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine-mediated behaviour following repeated electroconvulsive shock administration to rats.

Authors:  A R Green; P Johnson; V L Nimgaonkar
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

Review 5.  Electroconvulsive Therapy Intervention for Parkinson's Disease.

Authors:  Puneet Narang; Anna Glowacki; Steven Lippmann
Journal:  Innov Clin Neurosci       Date:  2015 Sep-Oct

6.  Diazepam administration to mice prevents some of the changes in monoamine-mediated behaviour produced by repeated electroconvulsive shock treatment.

Authors:  A R Green; J A Mountford
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Regional GABA concentration and [3H]-diazepam binding in rat brain following repeated electroconvulsive shock.

Authors:  J M Bowdler; A R Green; M C Minchin; D J Nutt
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

8.  Repeated ECS enhances dopamine D-1 but not D-2 agonist-induced behavioural responses in rats.

Authors:  T Sharp; J Kingston; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.